HOME >> MEDICINE >> NEWS
St. John's wort ineffective for depression

DURHAM, N.C. The largest clinical trial performed to date on the popular herbal supplement St. John's wort (Hypericum perforatum) has found it to be no more effective than placebo for the treatment of a moderately severe form of major depression, according to researchers at Duke University Medical Center. Major depression, also called major depressive disorder, is one of the most common forms of depression.

Researchers designed the study to test the efficacy of St. John's wort (SJW) versus placebo for the treatment of major depression. In their study, they used the antidepressant sertraline (trade name Zoloft), which is a selective serotonin reuptake inhibitor (SSRI), as a "control" to measure the sensitivity of the study for detecting antidepressant effects of hypericum. SSRIs such as sertraline are a class of drug found to be effective in treating several forms of depression.

"Major depression is treatable, but this research suggests that major depression of at least moderate severity should not be treated with St. John's wort," said Jonathan R.T. Davidson, M.D., director of the Anxiety and Traumatic Stress Program at Duke and principal investigator of the study. "Rather than self-medicate with an over-the-counter medication or supplement, patients are strongly advised to consult an appropriate healthcare provider to assess the best treatment for a depressive episode."

Another author on the study, Robert Califf, M.D., director of the Duke Clinical Research Institute, emphasized the dangers of inadequate studies of St. John's wort and other herbal remedies.

"As long as these types of products remain available to the public without the protection of adequate, controlled and unbiased studies, taking them is like playing Russian roulette with your health," he said.

Study results appear in the April 10, 2002 issue of the Journal of the American Medical Association. Duke University Medical Center, Duke Clinical Research Institute (DCRI)
'"/>

Contact: Tracey Koepke
koepk002@mc.duke.edu
919-684-4148
Duke University
9-Apr-2002


Page: 1 2 3 4 5

Related medicine news :

1. St. Johns wort amplifies effect of blood thinner Plavix
2. The effects of St. Johns Wort (Hypericum perforatum)
3. UT Southwestern Study To Test Efficacy Of St. Johns Wort For Treatment Of Depression
4. Study Finds St. Johns Wort Can Cut Alcohol Consumption
5. Government wasting your taxpayer money on ineffective drug cure
6. School-based smoking prevention programs ineffective
7. Surgical procedure to treat GERD in children found to be ineffective
8. Fetal heart monitoring ineffective at diagnosing cerebral palsy
9. Doubling of steroid before severe asthma attack ineffective
10. Promising drug proves ineffective as treatment for hearing loss
11. Screening children for speech problems is ineffective

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2020)... ... 2020 , ... Cecelia Health ( http://www.ceceliahealth.com ), a leading ... for over a decade to transform lives and health outcomes for patients and ... By optimizing the mix of expert clinician and digital touchpoints in clinically tested ...
(Date:1/10/2020)... ... January 10, 2020 , ... Sigma Theta Tau International ... Book of the Year Awards. These awards are regarded as one of the most ... year, the AJN Book of the Year competition has recognized Sigma for the last ...
(Date:1/10/2020)... ... 10, 2020 , ... WellHaven Pet Health, a family of companion animal veterinary ... coming in February 2020, LEAD WELL with WOMEN. The community will be showcased at ... of LEAD WELL with WOMEN is to empower women, engage all, connect, and help ...
(Date:1/10/2020)... ... January 10, 2020 , ... The value of healthy ... is via a preventative approach. Leading eye care doctor, Brent Bellotte MD., champions such ... many common eye diseases. , Eyesight is something that many take for granted until ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... Oregon, provides a friendly, non-intimidating environment for all women. In search for a ... its current and prospective members. , For nearly 30 years, Balanced Habits, ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a partnership ... Inc, operating under a tender from the Israeli Innovation Authority (IIA) has recently ... Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation biological ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... an affiliation agreement that officially brings GCMC into the family of hospitals affiliated ... City provides the network and its patients with a vital new access point ...
(Date:1/10/2020)... ... January 10, 2020 , ... Representatives with MyBioGate announced that they are ... partners conference will be held on 12 January 2020 at the Grand Hyatt ... be your gateway to China’s healthcare and life science industry. For the overseas biopharmas ...
Breaking Medicine Technology:
Cached News: